PLATFORM
TECHNOLOGY

New Treatment Modalities for Tomorrow

제목 없음-3.png

ߊ TRANSMAB®

​TRANSMAB® technology offers potential turnkey solution for brain-selective delivery of therapeutic antibody.

ߊ TRANSIRNA®

​TRANSIRNA® technology platform conjugates ​TRANSMAB® with oligonucleotide which offers potential solution for brain-related disorders. 

ߊ ​PIPELINE

TRANSMAB® TECHNOLOGY

TARGET

INDICATION

DISCOVERY

PRE-CLINICAL

EARLY CLINICAL

LATE CLINICAL

PARTNERSHIP

그림3.png

PD-L1

Alzheimer's

Undisclosed

Alzheimer's

Tau

Neurodegenerative

Undisclosed

Neuro-Oncology

Internal

Internal

Undisclosed

Internal

RNA TECHNOLOGY

TARGET

INDICATION

DISCOVERY

PRE-CLINICAL

EARLY CLINICAL

LATE CLINICAL

PARTNERSHIP

그림3.png

PMP22

Charcot-Marie-Tooth

Undisclosed